Vials containing HIBERIX are packaged separately from the prefilled diluent syringes
- Lyophilized vaccine comes in cartons of 10 vials1
- Sterile saline diluent comes in cartons of 10 disposable prefilled Tip-Lok® syringes1
- Prefilled diluent syringes do not contain vaccine
- Latex-free, no thimerosal
Upon administration, HCPs should record the lot number for the vaccine
How to reconstitute HIBERIX
- HIBERIX is a sterile, lyophilized powder (store refrigerated; protect from light)
- Use only the accompanying saline diluent for reconstitution
- HIBERIX should be administered as a 0.5-mL dose by intramuscular injection into the thigh or deltoid
- HIBERIX should be administered promptly after reconstitution or stored refrigerated between 2° and 8°C and administered within 24 hours
- Discard vaccine if not used within 24 hours of reconstitution, or if frozen
Indication
HIBERIX is indicated for active immunization as a booster dose for the prevention of invasive disease caused by Haemophilus influenzae type b (Hib). HIBERIX is approved for use in children 15 months through 4 years of age (prior to fifth birthday).
Important Safety Information
- In clinical studies, adverse events in children receiving HIBERIX included pain and redness at the injection site, fever, fussiness, loss of appetite, and restlessness
- A severe allergic reaction (eg, anaphylaxis) after a previous dose of any Hib or tetanus toxoid-containing vaccine or any component of HIBERIX is a contraindication
- If Guillain-Barré syndrome has occurred within 6 weeks of receipt of a prior vaccine containing tetanus toxoid, the decision to give HIBERIX should be based on potential benefits and risks
- Vaccination with HIBERIX may not protect 100% of susceptible individuals
References: 1. Prescribing Information for HIBERIX.